Nataliya Buxbaum

Assistant Professor of Oncology

Roswell Park Comprehensive Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Nataliya Buxbaum is an Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center in the United States. Her research focuses on graft-versus-host disease (GVHD), immune profiling in hematopoietic cell transplantation, and immunometabolic therapeutic targets. Recent publications include studies on immune tolerance subtypes in pediatric transplant recipients and the evolving path toward personalized treatment for chronic GVHD.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

takanori teshima

Hokkaido University

JAPAN

View details

Stephanie Lee

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Namita Sinha

Shared Health Manitoba

CANADA

View details

Jerome Ritz

Professor of Medicine, Harvard Medical School

Dana-Farber Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nataliya Buxbaum

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Mac-Man clearance of alloreactive T cells in GVHD

Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort

Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD

Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force

Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report

BAD(FF) to the bone: misbehaving B cells in cGVHD

Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI

Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation

Collaborators (4)

takanori teshima

Stephanie Lee

Namita Sinha

Jerome Ritz

Make your next move.